DOI:
10.1055/s-00000004
Aktuelle Neurologie
LinksClose Window
References
Hotta N, Toyota T, Matsuoka K. et al.
SNK-860 Diabetic Neuropathy Study Group. Clinical efficacy of fidarestat, a novel aldose reductase inhibitor, for diabetic peripheral neuropathy: a 52-week multicenter placebo-controlled double-blind parallel group study.
Diabetes Care 2001; 24: 1776-1782
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.